Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China · Delayed Price · Currency is CNY 27.95
-0.25 (-0.89%)
Nov 13, 2026, 3:00 PM CST
SHA:603351 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 169.4 | 423.87 | 247.2 | 157.55 | 99.83 | 66.26 |
Trading Asset Securities | 5 | - | - | 1.25 | 1.11 | 26.24 |
Cash & Short-Term Investments | 174.4 | 423.87 | 247.2 | 158.8 | 100.93 | 92.5 |
Cash Growth | -52.91% | 71.47% | 55.67% | 57.33% | 9.12% | -66.03% |
Accounts Receivable | 253.13 | 251.26 | 238.39 | 240.02 | 168.79 | 203.98 |
Other Receivables | 3.41 | 2.76 | 2.9 | 4.9 | 5.85 | 2.39 |
Receivables | 256.54 | 254.02 | 241.29 | 244.92 | 174.64 | 206.37 |
Inventory | 212.35 | 206.11 | 202.02 | 170.58 | 165.13 | 142.44 |
Other Current Assets | 42.98 | 22.15 | 26.69 | 25.13 | 29.58 | 23.38 |
Total Current Assets | 686.27 | 906.15 | 717.21 | 599.42 | 470.29 | 464.69 |
Property, Plant & Equipment | 1,431 | 1,432 | 1,449 | 1,499 | 1,482 | 1,212 |
Long-Term Investments | 115 | 116.83 | 83.41 | 71.29 | 68.79 | 40 |
Other Intangible Assets | 117.47 | 107.68 | 111.91 | 98.37 | 93.53 | 77.48 |
Long-Term Deferred Tax Assets | 5.38 | 4.89 | 6.9 | 9.25 | 5.98 | 11.69 |
Long-Term Deferred Charges | 1.41 | 0.75 | 0.28 | 0.35 | 1.33 | 2.43 |
Other Long-Term Assets | 34.6 | 25.95 | 12.25 | 1.23 | 16.58 | 33.42 |
Total Assets | 2,391 | 2,594 | 2,381 | 2,279 | 2,138 | 1,841 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 93.26 | 112.43 | 98.76 | 105.82 | 124.54 | 144.34 |
Accrued Expenses | 25.28 | 39.57 | 35.61 | 31.6 | 35.7 | 21.13 |
Short-Term Debt | 273.8 | 476.33 | 376.2 | 362.22 | 360.45 | 171.19 |
Current Portion of Long-Term Debt | 47.48 | 23.06 | 50.39 | 11.9 | 1.55 | 11.41 |
Current Portion of Leases | - | 8.74 | 7.34 | 8.77 | 7.67 | 3.69 |
Current Income Taxes Payable | 16.13 | 3.24 | 4.58 | 6.83 | 8.44 | 0.39 |
Current Unearned Revenue | 8.55 | 6.43 | 5.4 | 7.98 | 9.09 | 16.3 |
Other Current Liabilities | 38.06 | 25.85 | 17.63 | 22.62 | 32.58 | 54.25 |
Total Current Liabilities | 502.55 | 695.66 | 595.9 | 557.75 | 580.02 | 422.7 |
Long-Term Debt | - | 52 | 35 | 85.3 | 40 | - |
Long-Term Leases | 9.95 | 14.54 | 12.32 | 18.76 | 16.38 | 13.6 |
Long-Term Unearned Revenue | 17.33 | 11.61 | 13.88 | 12.71 | 6.5 | 6.74 |
Long-Term Deferred Tax Liabilities | 19.03 | 17.2 | 15.62 | 11.7 | 12.85 | 12.98 |
Total Liabilities | 548.86 | 791.01 | 672.72 | 686.22 | 655.76 | 456.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 135.44 | 135.44 | 135.44 | 135.44 | 135.48 | 135.48 |
Additional Paid-In Capital | 935.6 | 939.81 | 942.9 | 941.36 | 930.15 | 907.52 |
Retained Earnings | 758.99 | 720.21 | 623.42 | 517.63 | 443.36 | 388.98 |
Treasury Stock | - | - | - | -12.79 | -28.7 | -49.27 |
Comprehensive Income & Other | 2.51 | - | 0.16 | 2.79 | - | - |
Total Common Equity | 1,833 | 1,795 | 1,702 | 1,584 | 1,480 | 1,383 |
Minority Interest | 9.72 | 7.38 | 6.27 | 8.26 | 2.11 | 2.71 |
Shareholders' Equity | 1,842 | 1,803 | 1,708 | 1,593 | 1,482 | 1,385 |
Total Liabilities & Equity | 2,391 | 2,594 | 2,381 | 2,279 | 2,138 | 1,841 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 331.23 | 574.67 | 481.25 | 486.96 | 426.06 | 199.89 |
Net Cash (Debt) | -156.83 | -150.81 | -234.05 | -328.16 | -325.13 | -107.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.16 | -1.11 | -1.73 | -2.43 | -2.43 | -0.81 |
Filing Date Shares Outstanding | 135.44 | 135.44 | 135.44 | 135.44 | 135.48 | 135.48 |
Total Common Shares Outstanding | 135.44 | 135.44 | 135.44 | 135.44 | 135.48 | 135.48 |
Working Capital | 183.71 | 210.49 | 121.3 | 41.67 | -109.74 | 42 |
Book Value Per Share | 13.53 | 13.26 | 12.57 | 11.70 | 10.93 | 10.21 |
Tangible Book Value | 1,715 | 1,688 | 1,590 | 1,486 | 1,387 | 1,305 |
Tangible Book Value Per Share | 12.66 | 12.46 | 11.74 | 10.97 | 10.24 | 9.63 |
Buildings | - | 627.48 | 570.61 | 426.51 | 276.49 | 213.79 |
Machinery | - | 1,194 | 1,167 | 883.91 | 616 | 551.21 |
Construction In Progress | - | 140.66 | 128.71 | 494.95 | 835.2 | 643.27 |